Japans Megabanks Hit Record Profits but Analysts Caution on Sustainability Amid Rising Risks Saudi Arabias Vision 2030 Spending Spree Faces Reality Check EU Downgrades 2026 Growth Forecast as Strait of Hormuz Crisis Drives Energy Inflation AnheuserBusch InBev Shares Dip After Sales Miss Market Expectations Barclays Upgrades Transocean RIG to Overweight A Bullish Signal for Offshore Drilling THRY Q1 2026 Earnings Significant EPS Surprise Drives Positive Stock Reaction EXK Q1 2026 Earnings EPS Surges Past Estimates by Nearly 60 Yet Shares Dip LaZBoy LZB Q1 2026 Earnings EPS Falls Short as Consumer Demand Weakens ANET Q1 2026 Earnings EPS Beats Estimates by Nearly 6 Stock Climbs OZK Q1 2026 Earnings Marginal EPS Miss Amid Solid Underlying Performance HNNAZ Holds Steady at 2500 Par as Hennessy Advisors Notes Reflect Stable Credit Profile AO Smith AOS Holds Near Support After Modest Decline Design Therapeutics DSGN Consolidates Near Support After Marginal Decline Harvard Bioscience Slips as Traders Assess Support Levels HBIO Down Nearly 3 Real Messenger Warrants RMSGW Slide 64 as Shares Languish at 004 Support USA Rare Earth Inc USAR Declines 456 as Rare Earth Stocks Face Pressure Infighting and Legal Challenges Threaten Air Taxi Industrys LongAwaited Breakthrough CDNL Q1 2026 Earnings EPS Surges 2885 Above Estimates Dell Stock Surges 32 in Best Day Ever as AI Server Revenue Soars 757 Amarin Corporation AMRN Holds Steady Near Key Resistance After Modest Gains Liminatus Pharma Warrants LIMNW Hold Steady at 01 as Trading Lacks Direction Weibo WB Hovers Near Key Support Amid Modest Decline WM Technology MAPS Shows Resilience with 38 Gain Testing Key Resistance at 043 M3Brigade Acquisition V Corp MBAV Holds Steady Near 1081 Amid Minimal Price Movement Boston Scientific BSX Slips 163 as Stock Tests Key Support Levels QuantumScape QS Slips 5 to 867 Testing Support as EV Battery Sentiment Falters Centurion Acquisition Unit ALFUU Edges Higher as It Holds Above Key Support CD Rates Hold Steady at Up to 4 APY as of May 24 2026 ESLT Q4 2025 Earnings Strong EPS Beat Amid Defense Sector Demand Vistagen Therapeutics VTGN Slides 155 as Traders Eye Critical Support at 061